Diabetes HbA1c and vitamin status are more closely connected than many people realise. HbA1c — the key blood test used to assess long-term blood glucose control — can be influenced by nutritional deficiencies, while diabetes itself increases the risk of certain vitamin shortfalls. Vitamin B12 deficiency, common in people taking metformin, can falsely alter HbA1c readings and mimic diabetic neuropathy. Vitamin D deficiency is widespread in the UK population and may affect insulin sensitivity. Understanding how vitamins interact with HbA1c results and glucose metabolism is essential for accurate monitoring and safe, effective diabetes management in line with NHS and NICE guidance.

How HbA1c Reflects Long-Term Blood Sugar Control in Diabetes

HbA1c measures average blood glucose over 2–3 months by quantifying glucose bound to haemoglobin; in the UK, 48 mmol/mol or above confirms type 2 diabetes. Nutritional anaemias can distort results and must be excluded.

HbA1c — glycated haemoglobin — is the cornerstone blood test used to assess long-term blood glucose control in people with diabetes. When glucose circulates in the bloodstream, it binds irreversibly to haemoglobin within red blood cells, forming glycated haemoglobin. Because red blood cells have a lifespan of approximately 90–120 days, the HbA1c result reflects average blood glucose levels over the preceding two to three months, rather than a single point-in-time measurement.

In the UK, HbA1c is expressed in millimoles per mole (mmol/mol). According to NICE guidelines:

• Below 42 mmol/mol is considered normal

• 42–47 mmol/mol indicates non-diabetic hyperglycaemia (NDH)

• 48 mmol/mol or above is diagnostic of type 2 diabetes (when confirmed on a second test in the absence of symptoms)

For people already diagnosed with type 2 diabetes, NICE (NG28) recommends an HbA1c target of 48 mmol/mol (6.5%) for those managed by lifestyle measures or a single non-hypoglycaemic drug. Where treatment includes agents associated with a risk of hypoglycaemia — such as insulin or a sulfonylurea — a target of 53 mmol/mol (7.0%) is generally recommended. Targets should always be individualised, taking into account factors such as frailty, comorbidities, and patient preference.

It is important to understand that HbA1c is not suitable in all circumstances. It should not be used as the sole diagnostic test, or may give unreliable results, in the following situations:

• Pregnancy or recent pregnancy

• Children and young people

• Suspected type 1 diabetes

• Symptoms of diabetes present for fewer than two months

• Advanced chronic kidney disease (CKD)

• Haemoglobin variants (e.g., sickle cell trait, HbC, HbE) or haemoglobinopathies

• Recent blood transfusion or erythropoietin therapy

Certain nutritional deficiencies — particularly iron deficiency anaemia, vitamin B12 deficiency, and folate deficiency — can also affect red blood cell turnover and artificially alter HbA1c results, potentially leading to misinterpretation. This is a clinically significant consideration, particularly in people with diabetes who are at higher risk of nutritional deficiencies. Understanding the interplay between HbA1c and nutritional status is therefore essential for accurate diabetes monitoring and management.

Which Vitamin Deficiencies Are Common in People With Diabetes

Vitamin B12 deficiency is the most clinically significant concern, particularly in metformin users; vitamin D deficiency is also prevalent. Routine screening for all deficiencies is not mandated, but clinical vigilance is essential.

People living with diabetes are at increased risk of certain vitamin and micronutrient deficiencies, though the pattern and strength of evidence varies by nutrient and by diabetes type.

Vitamin D deficiency is particularly prevalent in people with type 2 diabetes, with research consistently showing lower serum vitamin D levels compared with the general population. Vitamin D plays a role in insulin secretion and insulin sensitivity, and deficiency has been associated with poorer glycaemic control, though causality remains under investigation. Vitamin D deficiency is also common in the general UK population, particularly during autumn and winter.

Vitamin B12 deficiency is a well-established concern in people taking metformin — one of the most commonly prescribed medications for type 2 diabetes in the UK. Metformin is thought to reduce intestinal absorption of vitamin B12, likely via impaired calcium-dependent uptake in the terminal ileum. Long-term or high-dose metformin use is associated with a clinically meaningful reduction in B12 levels. The MHRA has issued a Drug Safety Update advising that healthcare professionals should be alert to signs and symptoms of B12 deficiency in patients taking metformin, and should consider periodic monitoring in those at risk. B12 deficiency can cause peripheral neuropathy — a symptom that may be mistakenly attributed to diabetic neuropathy — as well as macrocytic anaemia.

Magnesium deficiency has the most consistent evidence base among minerals: low magnesium levels are associated with insulin resistance and impaired glucose metabolism, and urinary magnesium losses may be increased in the context of poorly controlled hyperglycaemia.

Other deficiencies sometimes reported in people with diabetes include:

• Folate (vitamin B9) — deficiency can cause macrocytic anaemia and is particularly relevant in women planning a pregnancy

• Vitamin C and zinc — some studies suggest lower levels in people with diabetes, though the evidence is less robust and routine screening is not recommended by NICE or NHS guidelines

Routine screening for all of these deficiencies is not universally mandated. Clinicians should maintain a low threshold for testing based on clinical symptoms, risk factors, and individual circumstances — particularly for B12 in patients on long-term metformin. Suspected adverse effects of metformin, including B12 deficiency, should be reported via the MHRA Yellow Card scheme.

Can Vitamins Affect HbA1c Readings and Glucose Metabolism

B12, folate, and iron deficiency can falsely elevate HbA1c by extending red blood cell lifespan; treating these deficiencies may lower HbA1c independently of any change in actual blood glucose control.

The relationship between vitamins and HbA1c is bidirectional: not only can diabetes affect vitamin levels, but certain vitamin deficiencies and supplementation can, in turn, influence HbA1c readings and underlying glucose metabolism.

Vitamin B12, folate, iron deficiency, and HbA1c: Iron deficiency anaemia, vitamin B12 deficiency, and folate deficiency can all reduce red blood cell turnover, meaning red cells remain in circulation longer than usual. This extended lifespan allows more time for glucose to bind to haemoglobin, potentially falsely elevating HbA1c results even when actual blood glucose control is reasonable. Conversely, conditions that increase red cell turnover — such as haemolytic anaemia — can falsely lower HbA1c. Clinicians should interpret HbA1c cautiously in patients with known nutritional anaemias.

Importantly, treating iron, B12, or folate deficiency can lower HbA1c independently of any real change in glycaemia, as red cell turnover normalises. In such situations, self-monitoring of blood glucose (SMBG) or continuous glucose monitoring (CGM), or an alternative measure such as fructosamine, may provide a more reliable assessment of glycaemic control.

High-dose vitamin C: High-dose vitamin C supplementation may interfere with some blood glucose meters and potentially with certain HbA1c assays. Patients should always disclose any supplements they are taking to their clinician or laboratory, particularly before blood tests.

Vitamin D and glucose metabolism: There is growing evidence that vitamin D supplementation may modestly improve insulin sensitivity and beta-cell function. Some studies suggest that correcting vitamin D deficiency in people with non-diabetic hyperglycaemia or early type 2 diabetes may contribute to small reductions in HbA1c, though the evidence is not yet strong enough to support routine supplementation solely for glycaemic benefit. NICE (NG28) does not recommend vitamin D or antioxidant vitamins as treatments to improve glycaemic control.

Antioxidant vitamins (C and E): High-dose supplementation with vitamins C and E has been studied for its potential to reduce oxidative stress in diabetes. However, evidence for meaningful HbA1c reduction remains inconsistent, and no UK clinical guideline recommends antioxidant supplementation for glycaemic management.

In summary, while vitamins can influence HbA1c accuracy and metabolic pathways, supplementation should be guided by confirmed deficiency rather than speculative benefit.

NHS Guidance on Vitamin Supplementation for People With Diabetes

NHS and NICE recommend targeted supplementation rather than blanket use; key guidance includes 10 micrograms of vitamin D daily in autumn and winter, and 5 mg folic acid for women with diabetes planning pregnancy.

The NHS and NICE do not recommend blanket vitamin supplementation for all people with diabetes. Instead, guidance is targeted, evidence-based, and tailored to individual clinical need. However, several specific recommendations are relevant to this population.

Vitamin D: UK Government and NHS guidance recommends that all adults consider taking a daily supplement of 10 micrograms (400 IU) of vitamin D during autumn and winter, as sunlight exposure is insufficient to maintain adequate levels during these months. This recommendation applies to the general population, including people with diabetes. Those at higher risk of deficiency — including people who are housebound, have darker skin tones, or cover most of their skin — are advised to supplement year-round. For most adults, supplementation can be started without prior blood testing; testing is generally reserved for those with symptoms or clinical indications of deficiency.

Vitamin B12 monitoring in metformin users: The BNF and MHRA Drug Safety Update advise that healthcare professionals should be alert to signs and symptoms of B12 deficiency in patients taking metformin, and should consider periodic monitoring in those at risk. Clinical indicators that should prompt B12 testing include:

• Symptoms of peripheral neuropathy (tingling, numbness, weakness)

• Macrocytic or unexplained anaemia

• Other features of B12 deficiency (fatigue, cognitive changes)

• Long-term or high-dose metformin use

There is no fixed duration threshold (such as '>3 years') specified in UK guidance; the decision to test should be based on clinical judgement and individual risk factors.

Folic acid: Women with diabetes who are planning a pregnancy are advised by NICE (NG3) to take 5 mg of folic acid daily (rather than the standard 400 micrograms), due to the increased risk of neural tube defects associated with diabetes in pregnancy. This should be started before conception and continued through the first trimester.

People with diabetes should be encouraged to maintain a balanced, varied diet in line with NHS Eatwell Guide principles, which remains the primary strategy for meeting nutritional requirements. Supplementation should complement — not replace — dietary measures.

When to Speak to Your GP About HbA1c and Vitamin Levels

Seek GP advice if HbA1c results are unexpectedly discordant with home glucose readings, or if you experience tingling, numbness, fatigue, or pallor that may indicate B12 or folate deficiency.

Not sure if this is normal? Chat with one of our pharmacists →

Knowing when to seek medical advice is an important aspect of self-management for people with diabetes. There are several circumstances in which it is advisable to contact your GP or diabetes care team regarding HbA1c results or potential vitamin deficiencies.

Regarding HbA1c:

• If your HbA1c result is unexpectedly high or low despite consistent self-monitoring of blood glucose — this discordance may indicate anaemia, chronic kidney disease, a haemoglobin variant, or an assay issue, all of which can affect HbA1c reliability

• If your HbA1c has risen significantly since your last test without an obvious explanation

• If you have been recently diagnosed with anaemia or another condition that may affect the reliability of your HbA1c result

• If you are unsure what your HbA1c target should be, or whether your current treatment plan is achieving it

Regarding vitamin deficiencies:

• If you experience tingling, numbness, or weakness in your hands or feet — these may indicate B12 deficiency or diabetic neuropathy, both of which require assessment

• If you feel persistently fatigued, breathless, or notice pallor, which may suggest anaemia related to B12 or folate deficiency

• If you are taking metformin and have symptoms or risk factors that suggest B12 deficiency, and have not had your levels checked

• If you are considering starting vitamin supplements, particularly in high doses, as some can interact with medications or affect test results — always disclose supplements to your care team

Regarding vitamin D: If you have symptoms that may suggest deficiency (such as bone pain, muscle weakness, or fatigue) or belong to a higher-risk group, speak to your GP, who can assess whether a blood test is appropriate. For most adults, following the UK Government's population supplementation advice (10 micrograms daily in autumn and winter) does not require prior testing.

Open communication with your healthcare team ensures that both glycaemic control and nutritional health are managed in a coordinated, safe manner. If you believe you have experienced a side effect from a medication such as metformin, this can be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Experiencing these side effects? Our pharmacists can help you navigate them →

Monitoring and Managing Both HbA1c and Nutritional Status

NICE recommends HbA1c monitoring every 3–6 months when targets are unmet and every 6 months when stable; nutritional concerns should be raised proactively at annual diabetes reviews alongside glycaemic assessment.

Effective diabetes management requires a holistic approach that addresses both glycaemic control and nutritional wellbeing. These two aspects are closely interlinked, and monitoring them together provides a more complete picture of a person's overall health.

HbA1c monitoring frequency is guided by NICE (NG28):

• Every 3–6 months when treatment has recently changed or targets are not being met

• Every 6 months once stable and on target

Alongside HbA1c, the annual diabetes review — offered through NHS primary care — typically includes assessment of renal function, lipid profile, blood pressure, and foot and eye health. Nutritional status is not always formally assessed unless symptoms prompt investigation. Patients and clinicians alike should be proactive in raising nutritional concerns during these reviews.

Practical strategies for managing both HbA1c and nutritional status include:

• Following a balanced diet rich in whole grains, vegetables, lean proteins, and healthy fats, in line with NHS Eatwell Guide principles

• Avoiding unnecessary restriction of food groups, which can inadvertently reduce intake of key vitamins and minerals

• Discussing any dietary supplements with a GP or registered dietitian before starting them, to avoid interactions or unwarranted reassurance

• Keeping a record of symptoms such as fatigue, neuropathy, or mood changes, which may signal nutritional deficiencies

• Attending all scheduled diabetes reviews and blood tests, including any additional tests recommended by your care team

• Participating in NHS structured diabetes education programmes — such as DESMOND (for type 2 diabetes) or DAFNE (for type 1 diabetes) — which support self-management skills including dietary understanding

For people with complex needs — such as those with renal impairment, coeliac disease, significant weight changes, or eating difficulties — referral to a specialist diabetes dietitian may be appropriate. Integrated care, combining glycaemic monitoring with nutritional assessment, remains the gold standard for long-term diabetes management in the UK.

Frequently Asked Questions